speb/financial-data huggingface dataset:
APRE balance_sheet (annual, 2024-12-31) — Total Capitalization: 19307455.00
APRE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 19307455.00
APRE income_statement (annual, 2024-12-31) — Total Expenses: 14319655.00
APRE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4672038.00
APRE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 403354.00
APRE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1311063.00
APRE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -14319655.00
APRE income_statement (annual, 2024-12-31) — Total Unusual Items: 71800.00
APRE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 71800.00
APRE balance_sheet (annual, 2024-12-31) — Working Capital: 20215164.00
APRE income_statement (quarterly, 2025-03-31) — +Operating Expense: 4085582.00
APRE income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
APRE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1281651.00
APRE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 351145676.00
APRE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 5993866.00
APRE income_statement (quarterly, 2025-03-31) — Basic EPS: -0.66
APRE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 22890055.00
APRE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 5513.00
APRE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 19275721.00
APRE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 19275721.00
APRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 55849.00
APRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
APRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3631163.00
APRE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -71935.00
APRE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 16521.00
APRE cash_flow (quarterly, 2025-03-31) — Change In Payable: -71935.00
APRE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -55414.00
APRE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 181044.00
APRE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 125630.00
APRE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3575314.00
APRE balance_sheet (quarterly, 2025-03-31) — Common Stock: 5513.00
APRE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 15549922.00
APRE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 59234.00
APRE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1690477.00
APRE balance_sheet (quarterly, 2025-03-31) — Current Assets: 19834410.00
APRE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3361098.00
APRE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5429.00
APRE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5429.00
APRE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 5993866.00
APRE income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.66
APRE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — EBIT: -4085582.00
APRE income_statement (quarterly, 2025-03-31) — EBITDA: -4080153.00
APRE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1398.00
APRE cash_flow (quarterly, 2025-03-31) — End Cash Position: 19316139.00
APRE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 55849.00
APRE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3631163.00
APRE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -51803.00
APRE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -10626736.00
APRE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1764979.00
APRE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 76093.00
APRE income_statement (quarterly, 2025-03-31) — Interest Income: 204726.00
APRE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 204726.00
APRE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 15549922.00
APRE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
APRE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 59234.00
APRE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 59234.00
APRE cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 51803.00
APRE income_statement (quarterly, 2025-03-31) — Net Income: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3932659.00
APRE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3932659.00
APRE income_statement (quarterly, 2025-03-31) — Net Interest Income: 204726.00
APRE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 204726.00
APRE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -3385.00
APRE balance_sheet (quarterly, 2025-03-31) — Net PPE: 76093.00
APRE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
APRE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 15549922.00
APRE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -4028350.00
APRE income_statement (quarterly, 2025-03-31) — Normalized Income: -3880856.00
APRE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3631163.00
APRE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 51803.00
APRE income_statement (quarterly, 2025-03-31) — Operating Income: -4085582.00
APRE income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
APRE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 5512656.00
APRE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 558689.00
APRE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -10626736.00
APRE income_statement (quarterly, 2025-03-31) — Other Gand A: 1764979.00
APRE income_statement (quarterly, 2025-03-31) — Other Income Expense: -51803.00
APRE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 311580.00
APRE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -162463.00
APRE balance_sheet (quarterly, 2025-03-31) — Other Properties: 76093.00
APRE balance_sheet (quarterly, 2025-03-31) — Payables: 1281651.00
APRE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2972128.00
APRE balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 388970.00
APRE balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 1311063.00
APRE income_statement (quarterly, 2025-03-31) — Pretax Income: -3932659.00
APRE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
APRE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5429.00
APRE income_statement (quarterly, 2025-03-31) — Research And Development: 2483066.00
APRE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -324974531.00
APRE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1764979.00
APRE balance_sheet (quarterly, 2025-03-31) — Share Issued: 5512656.00
APRE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 118634.00
APRE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 15549922.00
APRE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 15549922.00
APRE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
APRE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
APRE balance_sheet (quarterly, 2025-03-31) — Total Assets: 20222083.00
APRE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 15549922.00
APRE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 15549922.00
APRE income_statement (quarterly, 2025-03-31) — Total Expenses: 4085582.00
APRE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4672161.00
APRE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 387673.00
APRE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1311063.00
APRE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4085582.00
APRE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -51803.00
APRE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -51803.00
APRE balance_sheet (quarterly, 2025-03-31) — Working Capital: 16473312.00
APRE income_statement (quarterly, 2025-06-30) — +Operating Expense: 3387773.00
APRE income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
APRE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1195838.00
APRE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 352250747.00
APRE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 6083329.00
APRE income_statement (quarterly, 2025-06-30) — Basic EPS: -0.53
APRE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 19316139.00
APRE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5752.00
APRE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 16532199.00
APRE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 16532199.00
APRE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 384879.00
APRE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
APRE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3130754.00
APRE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -89670.00
APRE cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -140200.00
APRE cash_flow (quarterly, 2025-06-30) — Change In Payable: -89670.00
APRE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -229870.00
APRE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 166705.00
APRE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -63165.00
APRE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2745875.00
APRE balance_sheet (quarterly, 2025-06-30) — Common Stock: 5752.00
APRE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 13414681.00
APRE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 399785.00
APRE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1551190.00
APRE balance_sheet (quarterly, 2025-06-30) — Current Assets: 16927210.00
APRE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3167668.00
APRE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5428.00
APRE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5428.00
APRE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 6083329.00
APRE income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.53
APRE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — EBIT: -3387773.00
APRE income_statement (quarterly, 2025-06-30) — EBITDA: -3382345.00
APRE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 2608.00
APRE cash_flow (quarterly, 2025-06-30) — End Cash Position: 16572872.00
APRE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 384879.00
APRE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3130754.00
APRE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -29124.00
APRE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -10628417.00
APRE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1593671.00
APRE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 70665.00
APRE income_statement (quarterly, 2025-06-30) — Interest Income: 178027.00
APRE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 178027.00
APRE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 13414681.00
APRE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
APRE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 399785.00
APRE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 399785.00
APRE cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 29124.00
APRE income_statement (quarterly, 2025-06-30) — Net Income: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3238870.00
APRE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3238870.00
APRE income_statement (quarterly, 2025-06-30) — Net Interest Income: 178027.00
APRE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 178027.00
APRE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -14906.00
APRE balance_sheet (quarterly, 2025-06-30) — Net PPE: 70665.00
APRE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
APRE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 13414681.00
APRE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3353221.00
APRE income_statement (quarterly, 2025-06-30) — Normalized Income: -3209746.00
APRE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3130754.00
APRE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 29124.00
APRE income_statement (quarterly, 2025-06-30) — Operating Income: -3387773.00
APRE income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
APRE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 5752175.00
APRE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 395011.00
APRE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -10628417.00
APRE income_statement (quarterly, 2025-06-30) — Other Gand A: 1593671.00
APRE income_statement (quarterly, 2025-06-30) — Other Income Expense: -29124.00
APRE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 311835.00
APRE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -118111.00
APRE balance_sheet (quarterly, 2025-06-30) — Other Properties: 70665.00
APRE balance_sheet (quarterly, 2025-06-30) — Payables: 1195838.00
APRE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2747028.00
APRE balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 420640.00
APRE balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 727361.00
APRE income_statement (quarterly, 2025-06-30) — Pretax Income: -3238870.00
APRE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
APRE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5428.00
APRE income_statement (quarterly, 2025-06-30) — Research And Development: 1912213.00
APRE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -328213401.00
APRE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1593671.00
APRE balance_sheet (quarterly, 2025-06-30) — Share Issued: 5752175.00
APRE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 136729.00
APRE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 13414681.00
APRE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 13414681.00
APRE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
APRE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
APRE balance_sheet (quarterly, 2025-06-30) — Total Assets: 17309710.00
APRE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 13414681.00
APRE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 13414681.00
APRE income_statement (quarterly, 2025-06-30) — Total Expenses: 3387773.00
APRE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3895029.00
APRE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 382500.00
APRE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 727361.00
APRE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3387773.00
APRE income_statement (quarterly, 2025-06-30) — Total Unusual Items: -29124.00
APRE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -29124.00
APRE balance_sheet (quarterly, 2025-06-30) — Working Capital: 13759542.00
APRE income_statement (quarterly, 2025-09-30) — +Operating Expense: 3117388.00
APRE income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
APRE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 641322.00
APRE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 352722214.00
APRE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 6372938.00
APRE income_statement (quarterly, 2025-09-30) — Basic EPS: -0.47
APRE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 16572872.00
APRE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5979.00
APRE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 13718052.00
APRE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 13718052.00
APRE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 357940.00
APRE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
APRE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -3171230.00
APRE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -554020.00
APRE cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 60330.00
APRE cash_flow (quarterly, 2025-09-30) — Change In Payable: -554020.00
APRE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -493690.00
APRE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 169996.00
APRE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -323694.00
APRE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2813290.00
APRE balance_sheet (quarterly, 2025-09-30) — Common Stock: 5979.00
APRE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10912848.00
APRE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 375378.00
APRE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1450996.00
APRE balance_sheet (quarterly, 2025-09-30) — Current Assets: 13943988.00
APRE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2681107.00
APRE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5429.00
APRE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5429.00
APRE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 6372938.00
APRE income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.47
APRE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — EBIT: -3117388.00
APRE income_statement (quarterly, 2025-09-30) — EBITDA: -3111959.00
APRE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -600.00
APRE cash_flow (quarterly, 2025-09-30) — End Cash Position: 13758982.00
APRE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 357940.00
APRE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3171230.00
APRE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -5691.00
APRE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -10629534.00
APRE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1480319.00
APRE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 65236.00
APRE income_statement (quarterly, 2025-09-30) — Interest Income: 150669.00
APRE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 150669.00
APRE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 10912848.00
APRE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
APRE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 375378.00
APRE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 375378.00
APRE cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 5691.00
APRE income_statement (quarterly, 2025-09-30) — Net Income: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2972410.00
APRE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2972410.00
APRE income_statement (quarterly, 2025-09-30) — Net Interest Income: 150669.00
APRE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 150669.00
APRE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -17438.00
APRE balance_sheet (quarterly, 2025-09-30) — Net PPE: 65236.00
APRE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
APRE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10912848.00
APRE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3106268.00
APRE income_statement (quarterly, 2025-09-30) — Normalized Income: -2966719.00
APRE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -3171230.00
APRE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 5691.00
APRE income_statement (quarterly, 2025-09-30) — Operating Income: -3117388.00
APRE income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
APRE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5979292.00
APRE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 225936.00
APRE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -10629534.00
APRE income_statement (quarterly, 2025-09-30) — Other Gand A: 1480319.00
APRE income_statement (quarterly, 2025-09-30) — Other Income Expense: -5691.00
APRE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 312092.00
APRE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -1848.00
APRE balance_sheet (quarterly, 2025-09-30) — Other Properties: 65236.00
APRE balance_sheet (quarterly, 2025-09-30) — Payables: 641322.00
APRE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2092318.00
APRE balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 588789.00
APRE balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 727361.00
APRE income_statement (quarterly, 2025-09-30) — Pretax Income: -2972410.00
APRE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
APRE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5429.00
APRE income_statement (quarterly, 2025-09-30) — Research And Development: 1638917.00
APRE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -331185811.00
APRE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1480319.00
APRE balance_sheet (quarterly, 2025-09-30) — Share Issued: 5979292.00
APRE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 113754.00
APRE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10912848.00
APRE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 10912848.00
APRE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
APRE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
APRE balance_sheet (quarterly, 2025-09-30) — Total Assets: 14321316.00
APRE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 10912848.00
APRE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10912848.00
APRE income_statement (quarterly, 2025-09-30) — Total Expenses: 3117388.00
APRE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3408468.00
APRE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 377328.00
APRE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 727361.00
APRE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3117388.00
APRE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5691.00
APRE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5691.00
APRE balance_sheet (quarterly, 2025-09-30) — Working Capital: 11262881.00
APRE income_statement (annual, 2025-12-31) — +Operating Expense: 13233836.00
APRE income_statement (quarterly, 2025-12-31) — +Operating Expense: 2643093.00
APRE income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
APRE income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
APRE balance_sheet (annual, 2025-12-31) — Accounts Payable: 713668.00
APRE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 713668.00
APRE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -94155.00
APRE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -94155.00
APRE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 356709645.00
APRE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 356709645.00
APRE income_statement (annual, 2025-12-31) — Basic Average Shares: 6538722.00
APRE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7687961.00
APRE income_statement (annual, 2025-12-31) — Basic EPS: -1.93
APRE income_statement (quarterly, 2025-12-31) — Basic EPS: -0.32
APRE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 22890055.00
APRE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 13758982.00
APRE balance_sheet (annual, 2025-12-31) — Capital Stock: 8192.00
APRE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 8192.00
APRE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 14599347.00
APRE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 14599347.00
APRE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 14599347.00
APRE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 14599347.00
APRE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 4640238.00
APRE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3841570.00
APRE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
APRE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
APRE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -12894439.00
APRE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2961292.00
APRE cash_flow (annual, 2025-12-31) — Change In Account Payable: -646701.00
APRE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 68924.00
APRE cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -64488.00
APRE cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -1139.00
APRE cash_flow (annual, 2025-12-31) — Change In Payable: -646701.00
APRE cash_flow (quarterly, 2025-12-31) — Change In Payable: 68924.00
APRE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -711189.00
APRE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 67785.00
APRE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -217906.00
APRE cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -735651.00
APRE cash_flow (annual, 2025-12-31) — Change In Working Capital: -929095.00
APRE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -667866.00
APRE cash_flow (annual, 2025-12-31) — Changes In Cash: -8254201.00
APRE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 880278.00
APRE balance_sheet (annual, 2025-12-31) — Common Stock: 8192.00
APRE balance_sheet (quarterly, 2025-12-31) — Common Stock: 8192.00
APRE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 12441682.00
APRE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 5047606.00
APRE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 4213209.00
APRE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1280128.00
APRE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1280128.00
APRE balance_sheet (annual, 2025-12-31) — Current Assets: 15561246.00
APRE balance_sheet (quarterly, 2025-12-31) — Current Assets: 15561246.00
APRE balance_sheet (annual, 2025-12-31) — Current Liabilities: 2764358.00
APRE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2764358.00
APRE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 21715.00
APRE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5429.00
APRE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 21715.00
APRE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5429.00
APRE income_statement (annual, 2025-12-31) — Diluted Average Shares: 6538722.00
APRE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7687961.00
APRE income_statement (annual, 2025-12-31) — Diluted EPS: -1.93
APRE income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.32
APRE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2455630.00
APRE income_statement (annual, 2025-12-31) — EBIT: -13233836.00
APRE income_statement (quarterly, 2025-12-31) — EBIT: -2643093.00
APRE income_statement (annual, 2025-12-31) — EBITDA: -13212121.00
APRE income_statement (quarterly, 2025-12-31) — EBITDA: -2637664.00
APRE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 4679.00
APRE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 1273.00
APRE cash_flow (annual, 2025-12-31) — End Cash Position: 14640533.00
APRE cash_flow (quarterly, 2025-12-31) — End Cash Position: 14640533.00
APRE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 4640238.00
APRE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 3841570.00
APRE cash_flow (annual, 2025-12-31) — Free Cash Flow: -12894439.00
APRE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2961292.00
APRE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -95319.00
APRE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -8701.00
APRE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10634714.00
APRE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10634714.00
APRE income_statement (annual, 2025-12-31) — General And Administrative Expense: 6476560.00
APRE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1637591.00
APRE balance_sheet (annual, 2025-12-31) — Gross PPE: 153962.00
APRE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 153962.00
APRE income_statement (annual, 2025-12-31) — Interest Income: 652086.00
APRE income_statement (quarterly, 2025-12-31) — Interest Income: 118664.00
APRE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 652086.00
APRE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 118664.00
APRE balance_sheet (annual, 2025-12-31) — Invested Capital: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 12441682.00
APRE cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
APRE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
APRE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 5047606.00
APRE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 4213209.00
APRE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 5258.00
APRE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 5258.00
APRE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 5047606.00
APRE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 4213209.00
APRE cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 95319.00
APRE cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 8701.00
APRE income_statement (annual, 2025-12-31) — Net Income: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Net Income: -2455630.00
APRE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2455630.00
APRE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2455630.00
APRE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2455630.00
APRE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2455630.00
APRE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -12599569.00
APRE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2455630.00
APRE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2455630.00
APRE income_statement (annual, 2025-12-31) — Net Interest Income: 652086.00
APRE income_statement (quarterly, 2025-12-31) — Net Interest Income: 118664.00
APRE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 652086.00
APRE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 118664.00
APRE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -407459.00
APRE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -371730.00
APRE balance_sheet (annual, 2025-12-31) — Net PPE: 59807.00
APRE balance_sheet (quarterly, 2025-12-31) — Net PPE: 59807.00
APRE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
APRE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
APRE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 12441682.00
APRE income_statement (annual, 2025-12-31) — Normalized EBITDA: -13116802.00
APRE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2628963.00
APRE income_statement (annual, 2025-12-31) — Normalized Income: -12504250.00
APRE income_statement (quarterly, 2025-12-31) — Normalized Income: -2446929.00
APRE cash_flow (annual, 2025-12-31) — Operating Cash Flow: -12894439.00
APRE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2961292.00
APRE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 95319.00
APRE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 8701.00
APRE income_statement (annual, 2025-12-31) — Operating Income: -13233836.00
APRE income_statement (quarterly, 2025-12-31) — Operating Income: -2643093.00
APRE income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
APRE income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
APRE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 8192538.00
APRE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 8192538.00
APRE balance_sheet (annual, 2025-12-31) — Other Current Assets: 961899.00
APRE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 961899.00
APRE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -10634714.00
APRE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -10634714.00
APRE income_statement (annual, 2025-12-31) — Other Gand A: 6476560.00
APRE income_statement (quarterly, 2025-12-31) — Other Gand A: 1637591.00
APRE income_statement (annual, 2025-12-31) — Other Income Expense: -17819.00
APRE income_statement (quarterly, 2025-12-31) — Other Income Expense: 68799.00
APRE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 39050.00
APRE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 312348.00
APRE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 312348.00
APRE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 77500.00
APRE income_statement (annual, 2025-12-31) — Other Operating Expenses: -285759.00
APRE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -3337.00
APRE balance_sheet (annual, 2025-12-31) — Other Properties: 148704.00
APRE balance_sheet (quarterly, 2025-12-31) — Other Properties: 148704.00
APRE balance_sheet (annual, 2025-12-31) — Payables: 713668.00
APRE balance_sheet (quarterly, 2025-12-31) — Payables: 713668.00
APRE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1993796.00
APRE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1993796.00
APRE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 770562.00
APRE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 770562.00
APRE balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 727361.00
APRE balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 727361.00
APRE income_statement (annual, 2025-12-31) — Pretax Income: -12599569.00
APRE income_statement (quarterly, 2025-12-31) — Pretax Income: -2455630.00
APRE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 91.00
APRE cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
APRE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
APRE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 21715.00
APRE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5429.00
APRE income_statement (annual, 2025-12-31) — Research And Development: 7043035.00
APRE income_statement (quarterly, 2025-12-31) — Research And Development: 1008839.00
APRE balance_sheet (annual, 2025-12-31) — Retained Earnings: -333641441.00
APRE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -333641441.00
APRE income_statement (annual, 2025-12-31) — Selling General And Administration: 6476560.00
APRE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1637591.00
APRE balance_sheet (annual, 2025-12-31) — Share Issued: 8192538.00
APRE balance_sheet (quarterly, 2025-12-31) — Share Issued: 8192538.00
APRE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 478141.00
APRE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 109024.00
APRE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 12441682.00
APRE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 12441682.00
APRE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
APRE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
APRE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
APRE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
APRE balance_sheet (annual, 2025-12-31) — Total Assets: 15933401.00
APRE balance_sheet (quarterly, 2025-12-31) — Total Assets: 15933401.00
APRE balance_sheet (annual, 2025-12-31) — Total Capitalization: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 12441682.00
APRE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 12441682.00
APRE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 12441682.00
APRE income_statement (annual, 2025-12-31) — Total Expenses: 13233836.00
APRE income_statement (quarterly, 2025-12-31) — Total Expenses: 2643093.00
APRE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3491719.00
APRE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3491719.00
APRE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 372155.00
APRE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 372155.00
APRE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 727361.00
APRE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 727361.00
APRE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -13233836.00
APRE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2643093.00
APRE income_statement (annual, 2025-12-31) — Total Unusual Items: -95319.00
APRE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -8701.00
APRE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -95319.00
APRE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -8701.00
APRE balance_sheet (annual, 2025-12-31) — Working Capital: 12796888.00
APRE balance_sheet (quarterly, 2025-12-31) — Working Capital: 12796888.00
APRE income_statement (quarterly, 2026-03-31) — +Operating Expense: 3430412.00
APRE income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
APRE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2940756.00
APRE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 389631454.00
APRE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 14685448.00
APRE income_statement (quarterly, 2026-03-31) — Basic EPS: -0.22
APRE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 14640533.00
APRE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 11983.00
APRE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 46466202.00
APRE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 46466202.00
APRE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 34624149.00
APRE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2756726.00
APRE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 32525.00
APRE cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 218104.00
APRE cash_flow (quarterly, 2026-03-31) — Change In Payable: 32525.00
APRE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 250629.00
APRE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 181777.00
APRE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 432406.00
APRE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 31867423.00
APRE balance_sheet (quarterly, 2026-03-31) — Common Stock: 11983.00
APRE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 41588380.00
APRE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 35098813.00
APRE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1782493.00
APRE balance_sheet (quarterly, 2026-03-31) — Current Assets: 47245440.00
APRE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5296646.00
APRE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5428.00
APRE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5428.00
APRE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 14685448.00
APRE income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.22
APRE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — EBIT: -3430412.00
APRE income_statement (quarterly, 2026-03-31) — EBITDA: -3424984.00
APRE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -348.00
APRE cash_flow (quarterly, 2026-03-31) — End Cash Position: 46507608.00
APRE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 34624149.00
APRE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2756726.00
APRE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 7711.00
APRE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -10625700.00
APRE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1819245.00
APRE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 54379.00
APRE income_statement (quarterly, 2026-03-31) — Interest Income: 134784.00
APRE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 134784.00
APRE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 41588380.00
APRE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 35098813.00
APRE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 35098813.00
APRE cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -7711.00
APRE income_statement (quarterly, 2026-03-31) — Net Income: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3287917.00
APRE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3287917.00
APRE income_statement (quarterly, 2026-03-31) — Net Interest Income: 134784.00
APRE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 134784.00
APRE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -474664.00
APRE balance_sheet (quarterly, 2026-03-31) — Net PPE: 54379.00
APRE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 41588380.00
APRE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3432695.00
APRE income_statement (quarterly, 2026-03-31) — Normalized Income: -3295628.00
APRE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2756726.00
APRE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -7711.00
APRE income_statement (quarterly, 2026-03-31) — Operating Income: -3430412.00
APRE income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
APRE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 11982776.00
APRE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 779238.00
APRE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -10625700.00
APRE balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -499999.00
APRE income_statement (quarterly, 2026-03-31) — Other Gand A: 1819245.00
APRE income_statement (quarterly, 2026-03-31) — Other Income Expense: 7711.00
APRE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 312568.00
APRE balance_sheet (quarterly, 2026-03-31) — Other Properties: 54379.00
APRE balance_sheet (quarterly, 2026-03-31) — Payables: 2940756.00
APRE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4723249.00
APRE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 573397.00
APRE balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 727361.00
APRE income_statement (quarterly, 2026-03-31) — Pretax Income: -3287917.00